BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8478093)

  • 1. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.
    Inselburg J; Bathurst IC; Kansopon J; Barr PJ; Rossan R
    Infect Immun; 1993 May; 61(5):2048-52. PubMed ID: 8478093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.
    Inselburg J; Bathurst IC; Kansopon J; Barchfeld GL; Barr PJ; Rossan RN
    Infect Immun; 1993 May; 61(5):2041-7. PubMed ID: 8478092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.
    Inselburg J; Bzik DJ; Li WB; Green KM; Kansopon J; Hahm BK; Bathurst IC; Barr PJ; Rossan RN
    Infect Immun; 1991 Apr; 59(4):1247-50. PubMed ID: 1900809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
    Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
    Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
    Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).
    Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM
    Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
    Dutta S; Sullivan JS; Grady KK; Haynes JD; Komisar J; Batchelor AH; Soisson L; Diggs CL; Heppner DG; Lanar DE; Collins WE; Barnwell JW
    PLoS One; 2009 Dec; 4(12):e8138. PubMed ID: 19997632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF; Blackman MJ; Kaslow DC
    Infect Immun; 2000 Mar; 68(3):1418-27. PubMed ID: 10678955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK
    Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
    PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys.
    Collins WE; Walduck A; Sullivan JS; Andrews K; Stowers A; Morris CL; Jennings V; Yang C; Kendall J; Lin Q; Martin LB; Diggs C; Saul A
    Am J Trop Med Hyg; 2000 Apr; 62(4):466-79. PubMed ID: 11220762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants.
    Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kasumoto S
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):199-203. PubMed ID: 120768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
    Burghaus PA; Wellde BT; Hall T; Richards RL; Egan AF; Riley EM; Ballou WR; Holder AA
    Infect Immun; 1996 Sep; 64(9):3614-9. PubMed ID: 8751907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
    Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum.
    Herrera S; Herrera MA; Corredor A; Rosero F; Clavijo C; Guerrero R
    Am J Trop Med Hyg; 1992 Nov; 47(5):682-90. PubMed ID: 1449209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.